Suppr超能文献

息肉样脉络膜血管病变与中心性浆液性脉络膜视网膜病变病史

Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.

作者信息

Toyama T, Ohtomo K, Noda Y, Ueta T

机构信息

Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan.

出版信息

Eye (Lond). 2014 Aug;28(8):992-7. doi: 10.1038/eye.2014.132. Epub 2014 Jun 13.

Abstract

PURPOSE

To evaluate the possible causative role of central serous chorioretinopathy (CSC) in the development of exudative age-related macular degeneration (AMD).

METHODS

In a cross-sectional study at an institutional setting, 150 control subjects who had senile cataract or nasolacrimal duct stenosis and who were older than 50 years were enrolled. The background data for 89 patients with typical AMD (tAMD) and 138 patients with polypoidal choroidal vasculopathy (PCV) were used for comparison. Their medical records were taken for history of CSC, hypertension, systemic steroid use, and smoking. The fundus was also evaluated for signs of atrophic retinal pigment epithelial (RPE) tract and for focal photocoagulation scars in the macula.

RESULTS

After adjusting for age, gender, and history of hypertension, systemic steroid use, and smoking, history of CSC was significantly more frequent (P<0.0001) in patients with PCV (15 patients, 10.9%) compared with patients with tAMD (2 patients, 2.2%) or control subjects (0 patients). On fundoscopy, an atrophic RPE tract (seven patients) or a focal photocoagulation scar (one patient) was observed only in patients with PCV (eight patients, 5.8%), and the frequency was statistically significant compared with that with tAMD (P=0.0143) or control subjects (P=0.0143). The laterality of CSC and AMD involved the same eye in 9 of 10 patients among those who had unilateral AMD and a reported unilateral CSC history.

CONCLUSION

A history of CSC may be a predisposing factor for the development of PCV in the Japanese population.

摘要

目的

评估中心性浆液性脉络膜视网膜病变(CSC)在渗出性年龄相关性黄斑变性(AMD)发生发展中可能的致病作用。

方法

在一项机构性横断面研究中,纳入了150名年龄大于50岁、患有老年性白内障或鼻泪管狭窄的对照受试者。使用89例典型AMD(tAMD)患者和138例息肉状脉络膜血管病变(PCV)患者的背景数据进行比较。提取他们的病历以了解CSC病史、高血压、全身使用类固醇及吸烟情况。还对眼底进行评估,以检查萎缩性视网膜色素上皮(RPE)带的体征以及黄斑区的局灶性光凝瘢痕。

结果

在调整年龄、性别以及高血压、全身使用类固醇和吸烟史后,PCV患者中CSC病史的发生率(15例,10.9%)显著高于tAMD患者(2例,2.2%)或对照受试者(0例)(P<0.0001)。眼底检查发现,仅在PCV患者(8例,5.8%)中观察到萎缩性RPE带(7例患者)或局灶性光凝瘢痕(1例患者),与tAMD患者(P=0.0143)或对照受试者相比,该频率具有统计学意义(P=0.0143)。在单侧AMD且有单侧CSC病史报告的患者中,10例中有9例CSC和AMD累及同一只眼。

结论

在日本人群中,CSC病史可能是PCV发生的一个易感因素。

相似文献

1
Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.
Eye (Lond). 2014 Aug;28(8):992-7. doi: 10.1038/eye.2014.132. Epub 2014 Jun 13.
2
Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2309-2317. doi: 10.1007/s00417-018-4143-1. Epub 2018 Sep 27.
3
Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Ophthalmology. 2009 Dec;116(12):2400-6. doi: 10.1016/j.ophtha.2009.06.013. Epub 2009 Oct 7.
4
Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
Am J Ophthalmol. 2014 Dec;158(6):1155-1163.e1. doi: 10.1016/j.ajo.2014.08.010. Epub 2014 Aug 12.
7
Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2151-60. doi: 10.1007/s00417-015-2977-3. Epub 2015 Mar 7.
9
Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
Ophthalmol Retina. 2019 Sep;3(9):744-752. doi: 10.1016/j.oret.2019.04.018. Epub 2019 Apr 24.

引用本文的文献

1
Central Serous Chorioretinopathy Risk Factors in An Iranian Cohort: A Case-control Study.
J Ophthalmic Vis Res. 2023 Nov 30;18(4):410-416. doi: 10.18502/jovr.v18i4.14553. eCollection 2023 Oct-Dec.
2
The Application of Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography in Macular Diseases.
J Ophthalmol. 2020 Aug 24;2020:9503795. doi: 10.1155/2020/9503795. eCollection 2020.
4
Comparison of OCT and OCTA manifestations among untreated PCV, neovascular AMD, and CSC in Chinese population.
Int J Ophthalmol. 2020 Jan 18;13(1):93-103. doi: 10.18240/ijo.2020.01.14. eCollection 2020.
5
Remodeling of macular vortex veins in pachychoroid neovasculopathy.
Sci Rep. 2019 Oct 11;9(1):14689. doi: 10.1038/s41598-019-51268-9.
6
Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):279-288. doi: 10.1007/s00417-018-4201-8. Epub 2018 Dec 18.
7
and as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy.
Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6261-6266. doi: 10.1073/pnas.1802212115. Epub 2018 May 29.
8
Case series of coexistence of polypoidal choroidal vasculopathy with other rare fundus diseases.
Int Ophthalmol. 2019 May;39(5):987-990. doi: 10.1007/s10792-018-0900-8. Epub 2018 Mar 28.
9
Type 1 neovascularization with polypoidal lesions complicating dome shaped macula.
Int J Retina Vitreous. 2015 Jul 9;1:8. doi: 10.1186/s40942-015-0008-5. eCollection 2015.

本文引用的文献

2
Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability.
Am J Ophthalmol. 2013 Feb;155(2):305-313.e1. doi: 10.1016/j.ajo.2012.07.018. Epub 2012 Sep 27.
3
Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous chorioretionopathy.
Korean J Ophthalmol. 2012 Feb;26(1):15-20. doi: 10.3341/kjo.2012.26.1.15. Epub 2012 Jan 14.
4
Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.
Eye (Lond). 2011 Dec;25(12):1635-40. doi: 10.1038/eye.2011.258. Epub 2011 Oct 21.
5
Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration.
Ophthalmology. 2011 May;118(5):840-5. doi: 10.1016/j.ophtha.2010.09.012. Epub 2011 Jan 6.
6
Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Ophthalmology. 2010 Sep;117(9):1792-9. doi: 10.1016/j.ophtha.2010.01.023. Epub 2010 May 15.
7
Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.
Ophthalmology. 2010 Aug;117(8):1567-70. doi: 10.1016/j.ophtha.2009.12.018. Epub 2010 Apr 8.
8
Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
Ophthalmology. 2009 Dec;116(12):2400-6. doi: 10.1016/j.ophtha.2009.06.013. Epub 2009 Oct 7.
9
The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
Ophthalmology. 2008 Jan;115(1):169-73. doi: 10.1016/j.ophtha.2007.02.032.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验